|
WO2020257626A1
|
|
Methods of promoting vasculogenesis
|
|
WO2020097251A1
|
|
Methods of cellular reprogramming
|
|
TW201733600A
|
|
Fetal support tissue products and methods of use
|
|
WO2016187555A1
|
|
Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
|
|
WO2016138025A2
|
|
Apparatuses and methods for treating ophthalmic diseases and disorders
|
|
TW201628633A
|
|
Compositions and method for promoting nerve growth and regeneration
|
|
US2016008295A1
|
|
Compositions and methods for treating rosacea
|
|
CN106456675A
|
|
Compositions and methods
|
|
KR20150053753A
|
|
Compositions containing hc-ha/ptx3 complexes and methods of use thereof
|
|
US2013251684A1
|
|
Methods of isolating and culturing stem cells
|
|
CN103874762A
|
|
Methods of sterilizing fetal support tissues
|
|
WO2012170905A1
|
|
Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
|
|
WO2012149574A1
|
|
Methods of isolating cells
|
|
WO2011031489A2
|
|
Umbilical cord amniotic membrane products
|
|
CA2758571A1
|
|
Compositions containing hc-ha complex and methods of use thereof
|
|
CN104189091A
|
|
Compositions and methods for treating demodex infestations
|
|
CN104873956A
|
|
Amniotic Membrane Preparations And Purified Compositions And Methods Of Use
|
|
US2007010008A1
|
|
Ex vivo expansion of primary animal cells
|
|
US2009214676A1
|
|
Method for treating ocular demodex
|
|
WO2006094247A2
|
|
Amniotic membrane extracts, compositions thereof, and methods of use
|
